A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/2001
12/04/2001	US6325998 Methods of treating disease using recombinant adeno-associated virus virions administered to muscle
12/04/2001	CA2139948C Targeting somatic gene therapy to joints
12/04/2001	CA2024253C Entities for cancer therapy
11/2001
11/29/2001	WO2001090421A2 Method of detecting inflammatory lung disorders
11/29/2001	WO2001090392A1 Novel recombinant adenovirus vector with relieved side effects
11/29/2001	WO2001090391A2 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution
11/29/2001	WO2001090390A1 Use of baculovirus vectors in gene therapy
11/29/2001	WO2001090384A1 Viral vectors useful in induction of humoral or cellular immunity
11/29/2001	WO2001090382A2 Fas ligand-fused proteins
11/29/2001	WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	WO2001090365A2 Human protein kinase '13305' and uses therefor
11/29/2001	WO2001090345A2 Methods and compositions for enhancing the delivery of a nucleic acid to a cell
11/29/2001	WO2001090344A1 β-HCG PROMOTER BASED TUMOR-RESTRICTIVE GENE EXPRESSION FOR CANCER GENE THERAPY
11/29/2001	WO2001090342A2 Genetic engineering of vascular grafts to resist disease
11/29/2001	WO2001090341A1 Antisense modulation of pten expression
11/29/2001	WO2001090306A2 Compositions and methods for modulating tumor specific expression
11/29/2001	WO2001090302A2 Compositions and methods for production of rna viruses and rna virus-based vector particles
11/29/2001	WO2001090197A1 Synthetic peptides and uses therefore
11/29/2001	WO2001090189A2 G-protein coupled receptor org3.
11/29/2001	WO2001090160A2 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE
11/29/2001	WO2001090159A2 Compositions and methods for delivery of a molecule into a cell
11/29/2001	WO2001090158A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090154A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
11/29/2001	WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	WO2001090142A2 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS
11/29/2001	WO2001090139A2 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	WO2001089593A1 Transfection system
11/29/2001	WO2001089583A2 Glutamic acid decarboxylase (gad)_delivery system for treating neurodegenerative diseases
11/29/2001	WO2001089581A1 Medicinal compositions containing prostacyclin synthase gene
11/29/2001	WO2001089580A1 Systemic and cardiovascular transduction with lentiviral vectors
11/29/2001	WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	WO2001089564A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	WO2001089559A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	WO2001089554A2 Treatment of acute coronary syndrome with glp-1
11/29/2001	WO2001089548A2 Pharmaceutical use of fibulin-1
11/29/2001	WO2001089535A1 Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same
11/29/2001	WO2001089364A2 Hcv variants
11/29/2001	WO2001089304A1 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use
11/29/2001	WO2001062284A3 Novel method for down-regulation of amyloid
11/29/2001	WO2001055173A8 Nucleic acids, proteins, and antibodies
11/29/2001	WO2001047954A3 NOVEL cDNAs ENCODING CATENIN-BINDING PROTEINS WITH FUNCTION IN SIGNALLING AND/OR GENE REGULATION
11/29/2001	WO2001044465A3 Therapeutically useful synthetic oligonucleotides
11/29/2001	WO2001044458A3 Bovine immunodeficiency virus (biv) based vectors
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001042445A3 USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001040257A3 Modified il-12 subunits and nucleic acids encoding them
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001029234A3 Self-cleaving rna sequences and their use for the control of protein synthesis
11/29/2001	WO2001027304A3 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001023590A3 22196, a novel human aminopeptidase
11/29/2001	WO2001014546A3 Replication protein a binding transcriptional factor (rbt1) and uses thereof
11/29/2001	WO2001000864A3 Nucleic acid binding of multi-zinc finger transcription factors
11/29/2001	WO2000073469A3 Protein kinases
11/29/2001	WO2000061597A9 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
11/29/2001	WO2000047104A9 Antagonists of hmg1 for treating inflammatory conditions
11/29/2001	WO2000045792A8 Hydrogel particle formulations
11/29/2001	WO2000043505A3 Protease with two aspartate radicals in the catalytically active structure
11/29/2001	WO2000040722A3 Insulin-synthesis genes
11/29/2001	WO2000034310A9 Purified and isolated serine-threonine kinase receptors associated protein
11/29/2001	US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides
11/29/2001	US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors
11/29/2001	US20010047081 Adenoviral capsid containing chimeric protein IX
11/29/2001	US20010046967 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
11/29/2001	US20010046966 Gene therapy.
11/29/2001	US20010046965 Making them safer for the large-scale production of adenovirus stock for use in human gene therapy trials.
11/29/2001	US20010046959 Method of treating cancer with anti-neurotrophin agents
11/29/2001	US20010046705 Complex of nucleic acid and biodegradable cationic polyhydroxylated molecule (e.g., maltodextrin grafted with glycidyltrimethylammonium chloride); protects nucleic acid during transfection in to a cell
11/29/2001	US20010046491 Thymidine kinase mutant of herpes simplex virus and acyclovir, increased phosphorylation activity
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/29/2001	EP1144603A3 Protease
11/29/2001	DE10024383A1 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells
11/29/2001	DE10023887A1 Nucleic acid construct for transient cell transfection, useful ,e.g., in gene therapy, contains recombinase gene controlled by inducible promoter and flanking recombinase sites
11/29/2001	CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	CA2413326A1 Use of baculovirus vectors in gene therapy
11/29/2001	CA2410827A1 Methods and compositions for enhancing the delivery of a nucleic acid toa cell
11/29/2001	CA2410536A1 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use
11/29/2001	CA2410525A1 Fas ligand-fused proteins
11/29/2001	CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2410094A1 Compositions and methods for modulating tumor specific expression
11/29/2001	CA2409978A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
11/29/2001	CA2409874A1 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	CA2409873A1 Hcv variants
11/29/2001	CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	CA2408883A1 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
11/29/2001	CA2408743A1 Method of detecting inflammatory lung disorders
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408387A1 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	CA2408125A1 Synthetic peptides and uses therefore
11/29/2001	CA2407784A1 Treatment of acute coronary syndrome with glp-1
11/29/2001	CA2407570A1 Compositions and methods for delivery of a molecule into a cell
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158046A1 Superoxide Dismutase-4
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157999A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof

1 ... 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 ... 870